Biohaven Ltd. (NYSE:BHVN) has announced major breakthroughs with its novel precision immunology therapies, BHV-1400 and ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

IgA is an antibody. Antibodies are proteins made by your immune system. They protect your body from bacteria and viruses. When you have IgA nephropathy, some of the IgA your body makes has less of ...

Panelists discuss how step-therapy for immunoglobulin A (IgA) nephropathy is evolving toward a more personalized approach, ...

Samples were assessed for immune cells, antibodies, and immunoglobulins including Gd-IgA1. The analyses revealed that felzartamab induced rapid and durable depletion of Gd-IgA1 and total IgA ...

Data from a Phase I trial found it to be safe and well tolerated with early signs of clinical activity EPS 401 (formerly TIGA-001), an anti-EGFR IgA antibody with IND-enabling studies underway ...

An IgA anti-transglutaminase 2 (TGA-IgA) antibody cut-off of approximately 6.1 times the upper limit of normal optimised celiac disease diagnosis in children and adolescents with type 1 diabetes ...

It's stayed with the maverick approach with its purchase of TigaTx, as the US company focuses on IgA-based antibodies. Joining forces means that the combined company can now select "the most ...